All week, Cramer has been highlighting big pharma stocks that are poised to pop in the year to come. But the “Mad Money” host saved his fave stock...

Are big pharmaceutical stocks in the midst of a turnaround?. “A turnaround could be at hand,” "Mad Money" host Jim Cramer said. “After years where...

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in...

Momenta Pharmaceuticals (MNTA) shares plunged 21% Thursday after it lost a court ruling in its patent battle with Watson Pharmaceuticals (WPI) and...

Genzyme will begin shipping its Fabrazyme drug by the end of this month from its Framingham biotech factory, which has secured federal regulatory ...

Utility patents do not last forever. In fact, they last exactly twenty years, with few exceptions under the Hatch-Waxman Act. Pharmaceutical...

Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, is proud to offer Chattem's branded over-the-counter...

7,404,620 shares of Sanofi-Aventis (SNY) traded hands on Friday, a 123.86% increase in volume compared to its 20-day average. The stock last traded...

8,638,447 shares of Sanofi-Aventis (SNY) traded hands on Wednesday, a 127.03% increase in volume compared to its 20-day average. The stock last...

Regeneron Pharms (NASDAQ: REGN)'s stock had its "outperform" rating reaffirmed by equities research analysts at Leerink in a research note issued...